Skip to content
Review Open access

The Prospective Regulatory Functions of lncRNAs and Their ceRNA Networks in the Development of Motor Neurons and Associated Diseases

Aug 2026 · Biomolecules · Vol 16, pp. 1208 · 0 citations · 223 references
Medicine

TL;DR

The regulatory roles of lncRNA-associated ceRNA networks in motor neuron development are summarized, the evidence for their involvement in MNDs is evaluated, and their potential impact on disease progression is explored.

Abstract

Motor neurons form a highly specialized network composed of α-, β-, and γ-subtypes that coordinate skeletal muscle activity. Motor neuron diseases (MNDs), including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), are characterized by the progressive degeneration of this network, resulting in motor dysfunction. Emerging evidence underscores the significant roles of long non-coding RNAs (lncRNAs) in motor neuron development and disease. However, only a few have been experimentally confirmed as true ceRNA regulators, highlighting the need to differentiate validated mechanisms from mere associations or predictions. This review summarizes the regulatory roles of lncRNA-associated ceRNA networks in motor neuron development, evaluates the evidence for their involvement in MNDs, and explores their potential impact on disease progression. It also addresses current challenges, knowledge gaps, and future research directions for understanding ceRNA-mediated mechanisms and developing therapeutic strategies for MNDs.

Read PDF

Similar papers

Review Open access Aug 2026

Circular RNAs in amyotrophic lateral sclerosis.

RNA-seq data from ALS patients confirmed significant alterations in the expression of host genes of ALS-related circRNAs and hub proteins in ALS-affected CNS tissues, and these findings identify circRNAs as potential key contributors to ALS pathogenesis.

R. Ataei, J. Amini, N. Sanadgol et al. · 0 citations
Review Open access Aug 2026

The survival motor neuron protein: structure, functions, stability, and therapeutic targeting

This review examines the regulatory mechanisms that control SMN protein stability, collectively termed proteostasis, with a focus on how post-translational modifications coordinate with the ubiquitin-proteasome system and the autophagy-lysosomal pathway to govern protein turnover and clearance.

Bradley R. Smith, Rachel Massalee, Mason Mayer et al. · 0 citations
Open access Aug 2026

Integrative Nutrigenomic Systems Biology Analysis of Traditional Chinese Medicine Interventions in Parkinson’s Disease: Nutrient-Gene-Disease Network Perspectives

The combined model finds a mutual dysregulation of epigenetics and microRNA as the main cause of gene silencing, illustrating a neuro-nutrigenomic application in which dietary-derived and herbal compounds may modulate gene expression and epigenetic marks in Parkinson's disease.

Elham Amjad, B. Sokouti · 0 citations
Open access Aug 2026

Characterizing shared and distinctive molecular phenotypes across motor regions in ALS with and without TDP-43 pathology in a veteran cohort

These findings identify senescence-associated molecular states within vulnerable neuronal populations in ALS and support a model in which persistent stress adaptation may permit neuronal survival while contributing to progressive cellular dysfunction.

P. H. Doyle, Shiva Kazempour Dehkordi, Timothy C. Orr et al. · 0 citations
Review Open access Oct 2026

The emerging role of ER-localized TMEM proteins in neurodevelopmental disorders.

Neurodevelopmental disorders (NDDs) comprise a spectrum of conditions that impair brain development and nervous system function, resulting in lifelong cognitive, behavioral, and motor disabilities. Globally, more than 3% of children are affected by NDDs. Although advances in next-generation sequencing technology have i...

Shreni Priyadarshini, Rishi Kumar, Debdeep Dutta · 0 citations
Review Sep 2026

Uncovering hidden protein networks in Huntington’s disease: implications for pathogenesis and therapy

Investigations using various experimental techniques reveal that faulty neuroplasticity develops before the formation of visible protein aggregates, leading to synaptic dysfunction and specific loss of striatal medium spiny neurons in Huntington’s Disease.

Chhavi Panwar, Falguni Goel, Vipin Kumar Garg · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.